Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stern, Y.
Right arrow Articles by Mayeux, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stern, Y.
Right arrow Articles by Mayeux, R.
NEUROLOGY 1990;40:8
© 1990 American Academy of Neurology

Measurement and prediction of functional capacity in Alzheimer's disease

Yaakov Stern, PhD, Dale Hesdorffer, MPH, Mary Sano, PhD; and and Richard Mayeux, MD

Departments of Neurology (Dr. Stern, D. Hesdorffer, and Drs. Sano and Mayeux) and Psychiatry (Drs. Stern and Mayeux), Columbia University College of Physicians and Surgeons, New York, NY.

Functional loss in Alzheimer's disease is difficult to measure or predict. The Blessed Dementia Rating Scale (Part 1) correlates well with postmortem changes but is not an effective antemortem index of functional change since disparate behavorial domains are assessed. We performed a factor analysis of the Blessed items in 187 patients with clinically diagnosed Alzheimer's disease and identified 4 independent factors: (I) cognitive, (II) personality, (III) apathy, and (IV) basic self-care. An endpoint, consisting of a score indicative of moderate disability, was determined for each factor. We then used life table analyses to compare the probability of reaching these endpoints over time in longitudinally followed patients. Patients with extrapyramidal signs at their initial visit reached the factor IV endpoint sooner, and those with psychosis or no family history of dementia also reached the factor I endpoint faster. These data illustrate the utility of a multifactorial approach to the assessment of functional capacity in Alzheimer's disease, and also indicate that extrapyramidal symptoms and psychosis are powerful predictors of the rate of decline in basic self-care activities and cognition.

Address correspondence to Dr. Yaakov Stern, Neurological Institute, 710 West 168th Street, New York, NY 10032.

This work was supported by the Charles S. Robertson Memorial Gift for Alzheimer's Disease Research and by Federal Grants AG07370, AG07232, and AG08702. It was completed in the General Clinical Research Center, and data were analyzed on a CLINFO system (both RR00645).

Presented in part at the 113th annual meeting of the American Neurological Association, Philadelphia, PA, 1988.

Received May 12, 1989. Accepted for publication in final form June 23, 1989.




This article has been cited by other articles:


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
M. F. Weiner, B. Davis, K. Martin-Cook, L. S. Hynan, K. C. Saine, and C. Munro Cullum
A Direct Functional Measure to Help Ascertain Optimal Level of Residential Care
American Journal of Alzheimer's Disease and Other Dementias, November 1, 2007; 22(5): 355 - 359.
[Abstract] [PDF]


Home page
NeurologyHome page
K. Peres, V. Chrysostome, C. Fabrigoule, J. M. Orgogozo, J. F. Dartigues, and P. Barberger-Gateau
Restriction in complex activities of daily living in MCI: Impact on outcome
Neurology, August 8, 2006; 67(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
R. Holtzer, D. J. Wegesin, S. M. Albert, K. Marder, K. Bell, M. Albert, J. Brandt, and Y. Stern
The Rate of Cognitive Decline and Risk of Reaching Clinical Milestones in Alzheimer Disease
Arch Neurol, August 1, 2003; 60(8): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
AJGPHome page
P. A. Boyle, P. F. Malloy, S. Salloway, D. A. Cahn-Weiner, R. Cohen, and J. L. Cummings
Executive Dysfunction and Apathy Predict Functional Impairment in Alzheimer Disease
Am J Geriatr Psychiatry, April 1, 2003; 11(2): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. M. Brickman, A. Riba, K. Bell, K. Marder, M. Albert, J. Brandt, and Y. Stern
Longitudinal Assessment of Patient Dependence in Alzheimer Disease
Arch Neurol, August 1, 2002; 59(8): 1304 - 1308.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. H. Tabert, S. M. Albert, L. Borukhova-Milov, Y. Camacho, G. Pelton, X. Liu, Y. Stern, and D. P. Devanand
Functional deficits in patients with mild cognitive impairment: Prediction of AD
Neurology, March 12, 2002; 58(5): 758 - 764.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
L. Demers, M. Oremus, A. Perrault, N. Champoux, and C. Wolfson
Review of Outcome Measurement Instruments in Alzheimer's Disease Drug Trials: Psychometric Properties of Functional and Quality of Life Scales
J Geriatr Psychiatry Neurol, December 1, 2000; 13(4): 170 - 180.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. C. Marson, S. M. Sawrie, S. Snyder, B. McInturff, T. Stalvey, A. Boothe, T. Aldridge, A. Chatterjee, and L. E. Harrell
Assessing Financial Capacity in Patients With Alzheimer Disease: A Conceptual Model and Prototype Instrument
Arch Neurol, June 1, 2000; 57(6): 877 - 884.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
I. Gelinas, S. Gauthier, and PamelaA. Cyrus
Metrifonate Enhances the Ability of Alzheimer's Disease Patients to Initiate, Organize, and Execute Instrumental and Basic Activities of Daily Living
J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 9 - 16.
[Abstract] [PDF]


Home page
NeurologyHome page
C. R. Jack Jr, R. C. Petersen, Y. Xu, P. C. O'Brien, G. E. Smith, R. J. Ivnik, E. G. Tangalos, and E. Kokmen
Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease
Neurology, October 1, 1998; 51(4): 993 - 999.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. B. Tenser
Trigeminal neuralgia: Mechanisms of treatment
Neurology, July 1, 1998; 51(1): 17 - 19.
[Abstract] [Full Text] [PDF]


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
R. A. Sweet, M. Akil, B. H. Mulsant, R. Ulrich, R. E. Pasternak, and G. S. Zubenko
Determinants of SPontaneous Extrapyramidal Symptoms in Elderly Psychiatric Inpatients Diagnosed With Alzheimer's Disease, Major Depressive Disorder, or Psychotic Disorders
J Neuropsychiatry Clin Neurosci, February 1, 1998; 10(1): 68 - 77.
[Abstract] [Full Text]


Home page
NeurologyHome page
M. S. Mega, P. M. Thompson, J. L. Cummings, C. L. Back, M. L. Xu, S. Zohoori, A. Goldkorn, J. Moussai, L. Fairbanks, G. W. Small, et al.
Sulcal variability in the Alzheimer's brain: Correlations with cognition
Neurology, January 1, 1998; 50(1): 145 - 151.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Mathieu, P. Allard, G. Gobeil, M. Girard, M. De Braekeleer, and P. Begin
Anesthetic and surgical complications in 219 cases of myotonic dystrophy
Neurology, December 1, 1997; 49(6): 1646 - 1650.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Goto, N. Kunitoku, N. Soyama, K. Yamada, A. Okamura, M. Yoshikawa, Y. Hirata, E. Uyama, and Y. Ushio
Posteroventral pallidotomy in a patient with parkinsonism caused by hypoxic encephalopathy
Neurology, September 1, 1997; 49(3): 707 - 710.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. R. Jack Jr, R. C. Petersen, Y. C. Xu, S. C. Waring, P. C. O'Brien, E. G. Tangalos, G. E. Smith, R. J. Ivnik, and E. Kokmen
Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
Neurology, September 1, 1997; 49(3): 786 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L. Hokkanen and J. Launes
Cognitive recovery instead of decline after acute encephalitis: a prospective follow up study
J. Neurol. Neurosurg. Psychiatry, August 1, 1997; 63(2): 222 - 227.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Nuwer
Assessment of digital EEG, quantitative EEG, and EEG brain mapping: Report of the American Academy of Neurology and the American Clinical Neurophysiology Society
Neurology, July 1, 1997; 49(1): 277 - 292.
[Full Text] [PDF]


Home page
NeurologyHome page
W. C. Koller and E. B. Montgomery
Issues in the early diagnosis of Parkinson's disease
Neurology, July 1, 1997; 49(1_Suppl_1): S10 - S25.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Goto, S. Matsumoto, Y. Ushio, and A. Hirano
Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration
Neurology, October 1, 1996; 47(4): 1032 - 1036.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E.Ch. Wolters, E.N.H. Jansen, H. G. Tuynman-Qua, and P. L.M. Bergmans
Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease
Neurology, October 1, 1996; 47(4): 1085 - 1087.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. C. Meltzer, J. K. Zubieta, J. Brandt, L. E. Tune, H. S. Mayberg, and J. J. Frost
Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging
Neurology, August 1, 1996; 47(2): 454 - 461.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Ishigaki, S. Y. Patria, H. Nishio, M. Yabe, and M. Matsuo
A Japanese boy with myalgia and cramps has a novel in-frame deletion of the dystrophin gene
Neurology, May 1, 1996; 46(5): 1347 - 1347.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Ikoma, A. Samii, B. Mercuri, E. M. Wassermann, and M. Hallett
Abnormal cortical motor excitability in dystonia
Neurology, May 1, 1996; 46(5): 1371 - 1371.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. L. Pullman, B. Ford, B. Elibol, A. Uncini, P. C. Su, and S. Fahn
Cutaneous electromyographic silent period findings in brachial dystonia
Neurology, February 1, 1996; 46(2): 503 - 505.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Boiardi, A. Salmaggi, and A. Silvani
M-Bacod as first treatment for primary CNS lymphoma
Neurology, January 1, 1996; 46(1): 286 - 286.
[Full Text] [PDF]


Home page
NeurologyHome page
A. Das and F. H. Hochberg
Reply from the Authors: M-Bacod as first treatment for primary CNS lymphoma
Neurology, January 1, 1996; 46(1): 286 - 288.
[Full Text] [PDF]


Home page
NeurologyHome page
N. Mavroudakis, J. M. Caroyer, E. Brunko, and D. Z. de Beyl
Abnormal motor evoked responses to transcranial magnetic stimulation in focal dystonia
Neurology, September 1, 1995; 45(9): 1671 - 1677.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Galasko, S.D. Edland, J. C. Morris, C. Clark, R. Mohs, and E. Koss
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD).: Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years
Neurology, August 1, 1995; 45(8): 1451 - 1455.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Charletta, P.B. Gorelick, T.J. Dollear, S. Freels, and Y. Harris
CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia
Neurology, August 1, 1995; 45(8): 1456 - 1461.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I.N. van Schaik, P.M.M. Bossuyt, A. Brand, and M. Vermeulen
Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies: A meta-analysis
Neurology, August 1, 1995; 45(8): 1570 - 1577.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. M. Rabey, T. A. Treves, M. Y. Neufeld, E. Orlov, and A. D. Korczyn
Low-dose Clozapine in the Treatment of Levodopa-Induced Mental Disturbances in Parkinson's Disease
Neurology, March 1, 1995; 45(3): 432 - 434.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. H. Growdon and J.-P. Vonsattel
Case 17-1993- A 53-Year-Old Woman Who Died after Several Years of a Dementing Illness with Intermittent Generalized Seizures and Abnormal Movements of the Extremities and Head
N. Engl. J. Med., April 29, 1993; 328(17): 1259 - 1266.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by AAN Enterprises, Inc.